• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Ophthalmology and therapy. >Uveitis Specialists and Rheumatologists Select Different Therapies for Idiopathic Non-necrotizing Anterior Scleritis
【24h】

Uveitis Specialists and Rheumatologists Select Different Therapies for Idiopathic Non-necrotizing Anterior Scleritis

机译：葡萄膜炎专家和风湿病学家为特发性非坏死性前巩膜炎选择不同的疗法

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

IntroductionUveitis specialists and rheumatologists treat patients with anterior scleritis, but data from controlled trials to guide management are scarce, making differences in treatment paradigms possible. Methods1044 uveitis specialists and rheumatologists were surveyed regarding therapy for a patient with anterior scleritis. Respondents were asked to select first- and second-choice therapies and then reselect therapies assuming that the costs of all options were equal and that insurance approval was ensured. Fisher’s exact tests were employed to compare selections. ResultsNinety-two respondents (8.6%) completed the survey. Methotrexate was the most-selected first-choice treatment before equalization of cost/insurance factors among uveitis specialists (44.4%) and rheumatologists (78.6%) ( p ConclusionsUveitis specialists and rheumatologists have different preferences in the treatment of anterior scleritis. The difference is impacted more by specialty practice than by cost/insurance.
机译：引言葡萄膜炎专家和风湿病学家对患有前巩膜炎的患者进行治疗，但是从对照试验到指导治疗的数据很少，这使得治疗范式可能出现差异。方法对1044名葡萄膜炎专家和风湿病学家就前巩膜炎患者的治疗进行了调查。要求受访者选择第一和第二选择的疗法，然后在所有选择的费用均等且确保保险批准的前提下重新选择疗法。使用Fisher的精确测试来比较选择。结果有92位受访者（8.6％）完成了调查。甲氨蝶呤是葡萄膜炎专科医师（44.4％）和风湿病专科医师（78.6％）中成本/保险因素均等化之前的首选治疗方法（结论结论葡萄膜炎专科医生和风湿病专科医生在治疗前巩膜炎时有不同的偏好，差异会受到影响。通过专业实践而不是成本/保险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号